Stock listing
NASDAQ:ABCL AbCellera Biologics Inc. Stock
Home listing (NASDAQ) of AbCellera Biologics Inc.
Follow AbCellera Biologics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ABCL
$12.27 USD -0.81 (-6.2%)
Close on Oct 30, 2026
- Day range
- $11.75 – $12.91 USDOct 30, 2026
- Volume
- 3.87M sharesOct 30, 2026
- Market cap
- $3.98B USDAt the close on Oct 30, 2026 · price × 324.0M shares outstanding
- 52-week range
- $2.75 – $15.02 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $70.95M USDMedian day 4.55M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ABCL · Home | $12.27 USD | -0.81 (-6.2%) | 3,872,561 | $12.60 | $12.91 | $11.75 | $13.08 | Close on Oct 30, 2026 |
| Frankfurt:8QQ | €11.30 EUR | +0.02 (+0.2%) | — | €11.30 | €11.30 | €11.30 | €11.28 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ABCL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $12.27 | -0.81 | -6.2% | $12.60 | $12.91 | $11.75 | 3,872,561 | |
| $13.08 | -0.56 | -4.1% | $13.41 | $13.86 | $13.02 | 2,576,008 | |
| $13.64 | +0.81 | +6.3% | $12.67 | $13.65 | $12.65 | 3,043,223 | |
| $12.83 | +0.75 | +6.2% | $11.98 | $12.89 | $11.85 | 3,452,961 | |
| $12.08 | +0.26 | +2.2% | $12.00 | $12.42 | $11.78 | 3,033,875 | |
| $11.82 | +0.45 | +4.0% | $11.45 | $11.90 | $11.08 | 3,020,945 | |
| $11.37 | -0.87 | -7.1% | $12.00 | $12.23 | $11.21 | 4,262,189 | |
| $12.24 | +0.53 | +4.5% | $11.78 | $12.37 | $11.59 | 3,204,020 | |
| $11.71 | -0.22 | -1.8% | $11.61 | $11.95 | $11.41 | 4,226,419 | |
| $11.93 | +0.13 | +1.1% | $12.05 | $12.28 | $11.75 | 3,125,476 | |
| $11.80 | -0.88 | -6.9% | $12.68 | $12.68 | $11.72 | 4,112,108 | |
| $12.68 | +0.31 | +2.5% | $11.94 | $12.86 | $11.69 | 5,759,737 | |
| $12.37 | -0.24 | -1.9% | $12.37 | $12.84 | $12.26 | 3,058,826 | |
| $12.61 | -0.025 | -0.2% | $12.53 | $12.72 | $12.20 | 3,252,200 | |
| $12.64 | +0.09 | +0.7% | $12.71 | $13.06 | $12.43 | 5,752,100 | |
| $12.55 | +0.525 | +4.4% | $12.03 | $12.79 | $11.93 | 4,687,100 | |
| $12.02 | -0.81 | -6.3% | $12.54 | $12.63 | $11.89 | 8,523,000 | |
| $12.83 | -0.32 | -2.4% | $12.85 | $13.45 | $12.56 | 5,002,300 | |
| $13.15 | -0.63 | -4.6% | $14.00 | $14.53 | $12.93 | 9,789,900 | |
| $13.78 | +0.04 | +0.3% | $13.72 | $13.88 | $13.21 | 4,069,000 | |
| $13.74 | -0.17 | -1.2% | $14.10 | $14.30 | $13.66 | 3,714,400 | |
| $13.91 | -0.68 | -4.7% | $14.59 | $14.65 | $13.79 | 7,788,600 | |
| $14.59 | -0.23 | -1.6% | $14.78 | $15.02 | $14.56 | 4,863,800 | |
| $14.82 | +0.90 | +6.5% | $14.23 | $15.00 | $14.10 | 9,110,400 | |
| $13.92 | +1.22 | +9.6% | $12.44 | $14.23 | $12.38 | 7,832,000 | |
| $12.70 | +0.05 | +0.4% | $12.74 | $12.93 | $12.29 | 3,377,500 | |
| $12.65 | +0.34 | +2.8% | $12.02 | $12.68 | $11.78 | 4,988,100 | |
| $12.31 | -0.34 | -2.7% | $12.54 | $12.65 | $12.10 | 3,849,400 | |
| $12.65 | -0.01 | -0.1% | $12.56 | $12.97 | $12.49 | 4,282,000 | |
| $12.66 | +0.03 | +0.2% | $12.88 | $12.90 | $12.43 | 4,421,900 | |
| $12.63 | -0.10 | -0.8% | $12.73 | $12.96 | $12.37 | 5,432,700 | |
| $12.73 | +1.06 | +9.1% | $12.15 | $13.18 | $11.99 | 8,045,100 | |
| $11.67 | +0.26 | +2.3% | $11.44 | $11.73 | $11.18 | 4,545,000 | |
| $11.41 | +0.24 | +2.1% | $11.17 | $11.69 | $10.90 | 3,723,200 | |
| $11.17 | +0.28 | +2.6% | $10.66 | $11.31 | $10.66 | 4,446,200 | |
| $10.89 | +0.43 | +4.1% | $10.55 | $10.96 | $10.32 | 4,378,300 | |
| $10.46 | -0.59 | -5.3% | $10.79 | $11.07 | $10.42 | 4,944,600 | |
| $11.05 | -0.39 | -3.4% | $11.37 | $11.45 | $11.01 | 2,408,200 | |
| $11.44 | +0.01 | +0.1% | $11.29 | $11.64 | $11.10 | 2,557,000 | |
| $11.43 | -0.14 | -1.2% | $11.50 | $11.59 | $11.33 | 2,019,300 | |
| $11.57 | +0.21 | +1.8% | $11.58 | $11.82 | $11.26 | 3,284,600 | |
| $11.36 | +0.08 | +0.7% | $11.39 | $11.57 | $10.80 | 3,717,300 | |
| $11.28 | -0.20 | -1.7% | $11.24 | $11.52 | $11.05 | 4,246,900 | |
| $11.48 | +0.13 | +1.1% | $11.10 | $11.58 | $10.83 | 4,955,800 | |
| $11.35 | -1.05 | -8.5% | $12.31 | $12.35 | $11.26 | 5,861,200 | |
| $12.40 | +0.16 | +1.3% | $12.25 | $12.58 | $12.09 | 4,261,600 | |
| $12.24 | -0.26 | -2.1% | $12.22 | $12.36 | $12.05 | 5,025,500 | |
| $12.50 | +1.89 | +17.8% | $11.00 | $12.50 | $10.99 | 10,699,300 | |
| $10.61 | -0.71 | -6.3% | $10.97 | $11.01 | $10.44 | 6,591,400 | |
| $11.32 | -0.25 | -2.2% | $11.57 | $11.80 | $11.14 | 4,553,000 | |
| $11.57 | -0.44 | -3.7% | $11.82 | $12.08 | $11.40 | 6,181,600 | |
| $12.01 | +0.89 | +8.0% | $11.50 | $12.15 | $11.47 | 10,808,500 | |
| $11.12 | -0.08 | -0.7% | $10.80 | $11.52 | $10.70 | 8,201,800 | |
| $11.20 | -0.18 | -1.6% | $11.30 | $11.65 | $10.60 | 7,849,100 | |
| $11.38 | +0.41 | +3.7% | $10.84 | $11.50 | $10.47 | 12,375,100 | |
| $10.97 | +0.615 | +5.9% | $10.32 | $11.07 | $10.22 | 20,132,000 | |
| $10.36 | +0.595 | +6.1% | $9.22 | $10.38 | $9.00 | 14,854,500 | |
| $9.76 | +0.42 | +4.5% | $9.42 | $10.29 | $9.02 | 18,371,200 | |
| $9.34 | +2.41 | +34.8% | $8.76 | $10.01 | $8.40 | 46,039,100 | |
| $6.93 | +0.40 | +6.1% | $6.65 | $6.99 | $6.35 | 6,823,500 | |
| $6.53 | +0.61 | +10.3% | $5.79 | $6.565 | $5.62 | 8,412,100 | |
| $5.92 | -0.17 | -2.8% | $6.05 | $6.21 | $5.84 | 4,625,500 | |
| $6.09 | +0.26 | +4.5% | $5.97 | $6.14 | $5.87 | 3,968,400 | |
| $5.83 | +0.12 | +2.1% | $5.705 | $6.045 | $5.565 | 3,405,600 | |
| $5.71 | +0.02 | +0.4% | $5.70 | $5.87 | $5.51 | 5,011,700 | |
| $5.69 | +0.30 | +5.6% | $5.53 | $5.72 | $5.35 | 4,340,200 |
- Ticker
- NASDAQ:ABCL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
AbCellera to Present at Upcoming Investor Conferences in November 2026
Latest earnings call · Aug 5, 2026
Abcellera Biologics (NASDAQ:ABCL) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 10, 2026
Technical Presentation (August 2026)
Technical · 19 slides
Calls
Upcoming
Abcellera Biologics (NASDAQ:ABCL) Q3 2026 Earnings Call
Mon, Nov 09, 2026 · 6:00 PM ET
Register
Replays
Abcellera Biologics (NASDAQ:ABCL) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 5:00 PM ET
Watch TranscriptAbcellera Biologics (NASDAQ:ABCL) Q1 2026 Earnings Call
Mon, May 11, 2026 · 5:00 PM ET
Watch TranscriptAbcellera Biologics (NASDAQ:ABCL) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 5:00 PM ET
Watch Transcript
Latest news
AbCellera to Present at Upcoming Investor Conferences in November 2026
Oct 22, 2026
Closed $11.82 (+4.0%) on Oct 23, 2026
AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting
Oct 8, 2026
Closed $12.55 (+4.4%) on Oct 9, 2026
AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026
Oct 1, 2026
Closed $13.74 (-1.2%) on Oct 2, 2026
AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026
Sep 16, 2026
Closed $12.73 (+9.1%) on Sep 17, 2026
AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026
Sep 2, 2026
Closed $11.57 (+1.8%) on Sep 3, 2026
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants
Aug 13, 2026
Closed $10.97 (+5.9%) on Aug 13, 2026
AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Aug 11, 2026
Closed $10.36 (+6.1%) on Aug 12, 2026
AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile
Aug 10, 2026
Closed $9.34 (+34.8%) on Aug 10, 2026
AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026
Aug 7, 2026
Closed $9.34 (+34.8%) on Aug 10, 2026
Q2 2026 Business Update Presentation
Aug 5, 2026
Closed $6.53 (+10.3%) on Aug 6, 2026
Financings
Public offering of common shares and pre-funded warrants
Aug 13, 2026
Update: about US$200M · US$9.75 a share · Jefferies +4
Dealers: Jefferies (co-lead), J.P. Morgan (co-lead), Cantor (co-lead), UBS Investment Bank (co-lead), BMO Capital Markets (co-lead)
Use of proceeds: Research, development and clinical advancement of its internal pipeline including lead program ABCL635, working capital and general corporate purposes
Decks
Technical Presentation (August 2026)
Technical · 19 slides · Aug 10, 2026
Q2 2026 Earnings Presentation
Earnings · 13 slides · Aug 5, 2026
Q1 2026 Earnings Presentation
Earnings · 24 slides · May 11, 2026
Q1 2026 Earnings Presentation
Earnings · 32 slides · May 11, 2026
AbCellera Biologics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 161 in all · newest Oct 22, 2026 · oldest 2020
- Calls
- 23 calls with a replay · 23 with a transcript · latest Aug 5, 2026
- Decks
- 38 decks · latest Aug 10, 2026
Where AbCellera Biologics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ABCL · Home listing · This page | NASDAQ | United States | USD |
| gettex:8QQ | gettex | Germany | EUR |
| Tradegate:8QQ | Tradegate | Germany | EUR |
| LS Exchange:A2QKXS | LS Exchange | Germany | EUR |
| BOATS:ABCL | BOATS | United States | USD |
| Lang & Schwarz:A2QKXS | Lang & Schwarz | Germany | EUR |
| Frankfurt:8QQ | Frankfurt | Germany | EUR |
| BX Swiss:ABCL | BX Swiss | Switzerland | CHF |
| Dusseldorf:8QQ | Dusseldorf | Germany | EUR |
| Hamburg:8QQ | Hamburg | Germany | EUR |
| Munich:8QQ | Munich | Germany | EUR |
| Stuttgart:8QQ | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about AbCellera Biologics Inc.